Search research articles
Contact Us
Filters
Showing results (81-90 of 120) with videos related to
Page
of 12
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 22, 2014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study
Nezam H Afdhal, Bruce R Bacon, Keyur Patel, et al.
Hepatology (Baltimore, Md.)
|
April 22, 2006
Duration of peginterferon therapy in acute hepatitis C: a randomized trial
Sanaa M Kamal, Khairy N Moustafa, Jason Chen, et al.
Journal of Hepatology
|
December 8, 2016
Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir
David Wyles, Hadas Dvory-Sobol, Evguenia S Svarovskaia, et al.
The New England Journal of Medicine
|
November 30, 2007
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
John G McHutchison, Geoffrey Dusheiko, Mitchell L Shiffman, et al.
Hepatology (Baltimore, Md.)
|
August 18, 2016
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study
Elliot B Tapper, Bruce R Bacon, Michael P Curry, et al.
JCI Insight
|
January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis
Rohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Journal of Hepatology
|
October 27, 2011
Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1
Charles D Howell, Alexis Gorden, Kathleen A Ryan, et al.
The New England Journal of Medicine
|
August 24, 2012
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia
Nezam H Afdhal, Edoardo G Giannini, Ghias Tayyab, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 26, 2011
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C
Sarah J Schrieber, Roy L Hawke, Zhiming Wen, et al.
Gastroenterology
|
June 16, 2010
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction
Alexander J Thompson, Jacques Fellay, Keyur Patel, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 120) with videos related to
Sort By:
Page
of 12
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 22, 2014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study
Nezam H Afdhal, Bruce R Bacon, Keyur Patel, et al.
Hepatology (Baltimore, Md.)
|
April 22, 2006
Duration of peginterferon therapy in acute hepatitis C: a randomized trial
Sanaa M Kamal, Khairy N Moustafa, Jason Chen, et al.
Journal of Hepatology
|
December 8, 2016
Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir
David Wyles, Hadas Dvory-Sobol, Evguenia S Svarovskaia, et al.
The New England Journal of Medicine
|
November 30, 2007
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
John G McHutchison, Geoffrey Dusheiko, Mitchell L Shiffman, et al.
Hepatology (Baltimore, Md.)
|
August 18, 2016
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study
Elliot B Tapper, Bruce R Bacon, Michael P Curry, et al.
JCI Insight
|
January 26, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis
Rohit Loomba, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Journal of Hepatology
|
October 27, 2011
Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1
Charles D Howell, Alexis Gorden, Kathleen A Ryan, et al.
The New England Journal of Medicine
|
August 24, 2012
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia
Nezam H Afdhal, Edoardo G Giannini, Ghias Tayyab, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 26, 2011
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C
Sarah J Schrieber, Roy L Hawke, Zhiming Wen, et al.
Gastroenterology
|
June 16, 2010
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction
Alexander J Thompson, Jacques Fellay, Keyur Patel, et al.
Page
of 12